NO20033401D0 - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO20033401D0
NO20033401D0 NO20033401A NO20033401A NO20033401D0 NO 20033401 D0 NO20033401 D0 NO 20033401D0 NO 20033401 A NO20033401 A NO 20033401A NO 20033401 A NO20033401 A NO 20033401A NO 20033401 D0 NO20033401 D0 NO 20033401D0
Authority
NO
Norway
Prior art keywords
formula
chemical connections
present
beta
compounds
Prior art date
Application number
NO20033401A
Other languages
English (en)
Other versions
NO20033401L (no
Inventor
David Norman Deaton
Barry George Shearer
David Edward Uehling
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20033401D0 publication Critical patent/NO20033401D0/no
Publication of NO20033401L publication Critical patent/NO20033401L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • External Artificial Organs (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20033401A 2001-01-31 2003-07-30 Kjemiske forbindelser NO20033401L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0102408.2A GB0102408D0 (en) 2001-01-31 2001-01-31 Chemical compounds
PCT/US2001/049299 WO2002060885A1 (en) 2001-01-31 2001-12-17 Chemical compounds

Publications (2)

Publication Number Publication Date
NO20033401D0 true NO20033401D0 (no) 2003-07-30
NO20033401L NO20033401L (no) 2003-09-30

Family

ID=9907834

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033401A NO20033401L (no) 2001-01-31 2003-07-30 Kjemiske forbindelser

Country Status (23)

Country Link
EP (1) EP1366033B1 (no)
JP (1) JP2004521895A (no)
KR (1) KR20030070923A (no)
CN (1) CN1487928A (no)
AT (1) ATE294167T1 (no)
AU (1) AU2002246720B2 (no)
BR (1) BR0116854A (no)
CA (1) CA2434853A1 (no)
CZ (1) CZ20032085A3 (no)
DE (1) DE60110468T2 (no)
DK (1) DK1366033T3 (no)
ES (1) ES2240557T3 (no)
GB (1) GB0102408D0 (no)
HK (1) HK1060883A1 (no)
HU (1) HUP0303026A3 (no)
IL (2) IL156639A0 (no)
MX (1) MXPA03006847A (no)
NO (1) NO20033401L (no)
NZ (1) NZ526846A (no)
PL (1) PL363359A1 (no)
PT (1) PT1366033E (no)
WO (1) WO2002060885A1 (no)
ZA (1) ZA200305770B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
US7709677B2 (en) 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207964D0 (en) * 1992-04-10 1992-05-27 Ici Plc Chemical compounds
WO1995033724A1 (en) * 1994-06-09 1995-12-14 Glaxo Group Limited Phenethanolamine derivatives and their use as atypical beta-adrenoceptor agonists
GB9525177D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CZ20032085A3 (cs) 2003-12-17
DK1366033T3 (da) 2005-08-15
IL156639A (en) 2006-12-31
BR0116854A (pt) 2004-02-25
PL363359A1 (en) 2004-11-15
GB0102408D0 (en) 2001-03-14
HUP0303026A3 (en) 2007-06-28
PT1366033E (pt) 2005-08-31
NO20033401L (no) 2003-09-30
EP1366033B1 (en) 2005-04-27
MXPA03006847A (es) 2003-11-13
ATE294167T1 (de) 2005-05-15
DE60110468T2 (de) 2006-02-23
WO2002060885A1 (en) 2002-08-08
CA2434853A1 (en) 2002-08-08
KR20030070923A (ko) 2003-09-02
AU2002246720B2 (en) 2004-07-22
ZA200305770B (en) 2004-10-25
DE60110468D1 (de) 2005-06-02
EP1366033A1 (en) 2003-12-03
IL156639A0 (en) 2004-01-04
ES2240557T3 (es) 2005-10-16
JP2004521895A (ja) 2004-07-22
NZ526846A (en) 2004-10-29
CN1487928A (zh) 2004-04-07
HUP0303026A2 (hu) 2003-12-29
HK1060883A1 (en) 2004-08-27

Similar Documents

Publication Publication Date Title
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
EA200501771A1 (ru) Лиганды каннабиноидных рецепторов и их применения
DE602006010564D1 (de) Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
BG108225A (en) Thiohydantoins and use thereof for treating diabetes
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
UA86042C2 (en) Substituted indazole-o-glucosides
NO20055741L (no) Nye kjemiske forbindelser
ATE312096T1 (de) Neue verbindungen
DK1560812T3 (da) Aminocyclohexyletherforbindelser og anvendelser deraf
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
PT1267869E (pt) Antogonistas de receptor de glutamato metabotropico para o tratamento de tolerancia e de dependencia
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NL1021504A1 (nl) Waterstofbehandelingsproces.
SE0302304D0 (sv) Novel compounds
DE60135130D1 (de) Verwendung von substituierten pyrazolen zur behandlung von allergien
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
NO20033401D0 (no) Kjemiske forbindelser
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen
EP1436279A4 (en) CHEMICAL COMPOUNDS
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen